Metabolic Effects of Melatonin Treatment

NCT03859934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Disease
Insulin Sensitivity
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Type 2 Diabetes Mellitus
Blood Pressure
Inflammation

Interventions

DRUG: Melatonin
DRUG: Placebo Oral Tablet

Sponsor

University of Aarhus

Collaborators

[object Object]